U.S. RESEARCH ROUNDUP-Cimarex Energy, Dollar General, Werewolf Therapeutics
25/05/2021 08:00
May 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Cimarex Energy, Dollar General and Werewolf
Therapeutics, on Tuesday.
HIGHLIGHTS
* Aveanna Healthcare Holdings AVAH.O : Stephens initiates with overweight rating; PT $15
* Cimarex Energy Co XEC.N : Wells Fargo cuts to equal weight rating
* Dollar General Corp DG.N : Raymond James raises target price to $235 from $220
* Vaccitech Plc VACC.O : William Blair initiates coverage with outperform rating
* Werewolf Therapeutics Inc HOWL.O : Jefferies initiates coverage with buy rating; PT $22
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
* Ansys Inc ANSS.O : CFRA raises target price by $14 to $430
* Aveanna Healthcare Holdings AVAH.O : Stephens initiates with overweight rating; PT $15
* Beam Global BEEM.O : Cowen and Company cuts target price to $29 from $45
* Best buy Co Inc BBY.N : Raymond James raises target price to $130 from $120
* Cabot Oil & Gas Corp COG.N : Credit Suisse cuts target price to $19 from $20
* Cabot Oil & Gas Corp COG.N : Wells Fargo raises target price to $24 from $22
* Cimarex Energy Co XEC.N : Wells Fargo cuts to equal weight rating
* Coinbase Global Inc COIN.O : JP Morgan starts with overweight rating; $371 price target
* Dollar General Corp DG.N : Raymond James raises target price to $235 from $220
* Fluor Corp FLR.N : Baird cuts target price to $22 from $24
* H & R Block Inc HRB.N : Barrington Research raises target price to $28 from $24
* H & R Block Inc HRB.N : Jefferies raises target price to $26 from $21
* Lordstown Motors Corp RIDE.O : BTIG cuts target price to $20 from $40
* NGM Biopharmaceuticals Inc NGM.O : Cowen and Company cuts PT to $20 from $30
* NGM Biopharmaceuticals Inc NGM.O : Raymond James cuts target price to $22 from $52
* NGM Biopharmaceuticals Inc NGM.O : Raymond James cuts to outperform from strong buy
* Ormat Technologies Inc ORA.N : Cowen and Company raises target price to $73 from $72
* Ormat Technologies Inc ORA.N : JP Morgan raises target price to $83 from $81
* Strongbridge Biopharma Plc SBBP.O : Jefferies cuts target price to $3.5 from $5
* UDR Inc UDR.N : JP Morgan raises target price to $48 from $46
* Vaccitech Plc VACC.O : Jefferies initiates coverage with buy rating; target price $28
* Vaccitech Plc VACC.O : William Blair initiates coverage with outperform rating
* Ventas Inc VTR.N : Raymond James raises target price to $61 from $54
* Verastem Inc VSTM.O : BTIG raises to buy from neutral
* Werewolf Therapeutics Inc HOWL.O : Jefferies initiates coverage with buy rating; PT $22
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))